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Summary 
Double-stranded RNA (dsRNA) is a potent proinflammatory signature of viral infection. Long 
cytosolic dsRNA is recognized by MDA5. The cooperative assembly of MDA5 into helical 
filaments on dsRNA nucleates the assembly of a multiprotein type-I-interferon signaling 
platform. Here, we determined cryoEM structures of MDA5-dsRNA filaments with different 
helical twists and bound nucleotide analogs, at resolutions sufficient to build and refine atomic 
models. The structures identify the filament forming interfaces, which encode the dsRNA 
binding cooperativity and length specificity of MDA5. The predominantly hydrophobic interface 
contacts confer flexibility, reflected in the variable helical twist within filaments. Mutation of 
filament-forming residues can result in loss or gain of signaling activity. Each MDA5 molecule 
spans 14 or 15 RNA base pairs, depending on the twist. Variations in twist also correlate with 
variations in the occupancy and type of nucleotide in the active site, providing insights on how 
ATP hydrolysis contributes to MDA5-dsRNA recognition. 
Introduction 
Recognition of viral nucleic acids by innate immune receptors is one of the most conserved 
and important mechanisms for sensing viral infection. Many viruses deliver or generate 
double-stranded RNA (dsRNA) in the cytosol of the host cell. RNA duplexes have the A-form 
double helix structure distinct from the B-form structure of DNA (Pabit et al., 2016), and 
cytosolic dsRNA is a potent proinflammatory signal in vertebrates. Uninterrupted RNA 
duplexes longer than a few hundred base pairs (bp) are recognized in the cytosol by the innate 
immune receptor MDA5 (melanoma differentiation-associated gene-5; Kato et al., 2008; Kato 
et al., 2006). The cooperative assembly of MDA5 into ATP-sensitive filaments on dsRNA 
induces oligomerization of its tandem N-terminal caspase recruitment domains (CARDs) 
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(Berke and Modis, 2012; Peisley et al., 2011). The MDA5 CARD oligomers nucleate the 
growth of microfibrils of the CARD from MAVS (mitochondrial antiviral signaling protein) (Hou 
et al., 2011; Wu et al., 2014). The amyloid-like properties of MAVS CARD microfibrils initiate 
the assembly and growth of a multimeric signaling platform on the outer mitochondrial 
membrane, which includes proteins from the TRAF and TRIM families (Hou et al., 2011). The 
MAVS signalosome activates both type I interferon and NF-B inflammatory responses (Hou 
et al., 2011; Kato et al., 2008; Kato et al., 2006). The assembly of MDA5 filaments on dsRNA 
also efficiently displaces viral proteins from the RNA while promoting dsRNA-binding and 
activation of Protein Kinase R (Yao et al., 2015), which leads to inhibition of protein translation 
and hence virus replication (Chung et al., 2018). This effector activity of MDA5 is ATP-
dependent but CARD-independent (Yao et al., 2015). 
Recently, it was shown that mRNA containing Alu repeats, endogenous retroelements of viral 
origin constituting 10% of the human genome, can hybridize into long RNA duplexes that must 
be deaminated by ADAR1 to avoid recognition by MDA5 (Ahmad et al., 2018). A-to-I 
deamination by ADAR1 destabilizes the of Alu:Alu duplex sufficiently to prevent MDA5 filament 
formation. Gain-of-function MDA5 mutations or ADAR1 deficiency can cause PKR-mediated 
translational shutdown and severe autoimmune disorders, including Aicardi-Goutières 
syndrome (AGS), Singleton-Merten syndrome (SMS) and other interferonopathies (Ahmad et 
al., 2018; Chung et al., 2018; Rice et al., 2014; Rutsch et al., 2015). 
Crystal structures show that MDA5 binds dsRNA oligonucleotides with a modified DExD/H-
box helicase core and a C-terminal domain (CTD) (Uchikawa et al., 2016; Wu et al., 2013). 
The helicase consists of two RecA-like domains, Hel1 and Hel2, and an insert domain, Hel2i, 
all of which form contacts with phosphate and ribose moieties of both RNA strands. The 
helicase and CTD, linked by a pair of -helices referred to as the pincer domain, form a closed 
ring around the RNA. The overall structure is similar to those of two other helicases in the 
same subfamily, RIG-I and LGP2 (Jiang et al., 2011; Kowalinski et al., 2011; Luo et al., 2011; 
Uchikawa et al., 2016). However, the CTDs of RIG-I and LGP2 bind dsRNA blunt ends, with 
5’-di- or triphosphate caps and unphosphorylated, respectively, and both proteins have a much 
lower propensity than MDA5 to form filaments (Devarkar et al., 2016; Goubau et al., 2014; Luo 
et al., 2012). A structure of MDA5 bound to viral dsRNA determined by negative-stain electron 
microscopy at 22 Å resolution showed that MDA5 forms a polar, single-start helix on dsRNA 
and suggested that in MDA5 the CTD participates in filament formation rather than dsRNA 
blunt end recognition, but the resolution was insufficient to identify specific intermolecular 
interfaces (Berke et al., 2012). 
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The dsRNA binding cooperativity and length specificity of MDA5—which are critical for its 
signaling activity—are encoded by the filament-forming interfaces, but these remain unknown. 
Here, we determined the structures of the MDA5-dsRNA filament by cryo-electron microscopy 
(cryoEM) in different helical twist states and nucleotide binding states at local resolutions of 
up to 3.42 Å, allowing us to build and refine atomic models of the filaments. The structures 
reveal a predominantly hydrophobic pair of filament forming interfaces with the requisite 
flexibility to accommodate the mechanical properties of dsRNA (Herrero-Galan et al., 2013). 
Structures bound to ATP, ground state analog AMPPNP, transition state analog ADP-AlF4 and 
no nucleotide show how the ATPase cycle is coupled to changes in helical twist and the mode 
of dsRNA binding of MDA5. This work shows how MDA5 recognizes long dsRNA ligands and 
provides a structural basis for its proposed proofreading activity. 
Results 
MDA5-dsRNA filaments have a variable helical twist 
MDA5-dsRNA filaments were assembled by incubating recombinant mouse MDA5 with 
dsRNA in the presence of either ATP, the nonhydrolyzable ATP (ground state) analog 
AMPPNP, or the transition state analog ADP-AlF4. A concentration range of 1 – 10 mM of 
nucleotide was selected for a favorable trade-off between filament stabilization and vitreous 
ice formation, while remaining near the physiological range of cellular ATP concentration. 
Residues 646-663, in a flexible surface loop of Hel2i, were deleted to improve solubility, 
resulting in a 114 kDa polypeptide chain. This “∆L2” deletion did not interfere with the ATPase, 
dsRNA binding or interferon signaling activities of MDA5 (Berke et al., 2012; Wu et al., 2013). 
Power spectra from raw cryoEM images showed meridional reflections confirming the 
previously determined helical rise of approximately 44 Å (Berke et al., 2012; Figure S1). The 
high average curvature and variability in helical twist of the filaments presented challenges for 
helical image reconstruction. A cylinder was used as the initial model for 3D image 
reconstruction, along with the experimentally determined helical symmetry parameters (STAR 
Methods; Berke et al., 2012). To deal with sample heterogeneity, particles were divided into 
several classes during 3D image reconstruction. Most of the variability between classes was 
in the helical twist. There was no evidence for discrete twist states, and the number of classes 
used was arbitrary. Individual filaments contained segments with different twists (Figure 1B). 
Segments of similar twist formed small clusters, indicating that the variability in twist was a 
local phenomenon. Some twist values occurred more frequently than others and the twist 
distribution depended on type and occupancy the nucleotide bound (Figure 1C). Helical 
reconstruction of the filaments formed with 1 mM AMPPNP in RELION (He and Scheres, 
2017) produced three maps with an overall resolution better than 4 Å (3.68 – 3.93 Å) (Table 
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1, Figures S2-S3). The maps had distinct helical twists of 74˚, 87˚ and 91˚, respectively, but 
similar rises (43 – 45 Å). With local resolutions up to 3.42 Å, the maps, referred to henceforth 
as Twist74, Twist87 and Twist91, were sufficiently detailed for atomic models to be built and 
refined into each map using the crystal structures of human and chicken MDA5 bound to 
dsRNA oligonucleotides as starting models (Uchikawa et al., 2016; Wu et al., 2013) (Figures 
1D-E and S3). Reconstructions of filaments formed with 2.5 mM AMPPNP, 10 mM ATP, 2 mM 
ADP-AlF4 and without nucleotide were subsequently obtained with resolutions of 3.87 – 4.06 
Å. Filaments formed with ATP were frozen 7 – 8 minutes after addition of ATP to the sample, 
to prevent ATP hydrolysis from proceeding to completion. Most of the filaments formed with 
10 mM ATP had low helical twist (71˚ – 81˚), and most of the filaments formed without 
nucleotide had high helical twist (91˚ – 96˚). The filaments formed with ADP-AlF4 had a 
narrower distribution of intermediate twists (81˚ – 91˚) (Figure 1C). Filaments formed with 2.5 
mM AMPPNP had twists spanning a similarly broad range as with 1 mM AMPPNP (71˚ – 96˚). 
Overall structure of the MDA5-dsRNA filaments 
In the cryoEM structures presented here, MDA5 forms a closed ring around the RNA (Figure 
2 and Movie S1). The low-twist structures (71˚ – 81˚) contain 14 bp of dsRNA in the 
asymmetric unit and density for nucleotide bound in the ATP binding site. The intermediate-
twist (81˚ – 91˚) and high-twist (91˚ – 96˚) structures have 15 bp of dsRNA and no interpretable 
density in the catalytic site. The nucleotide density ranges from absent or weak in the 
nucleotide-free structures and the 1-mM AMPPNP low-twist structure (Twist74), respectively, 
to strong in the intermediate-twist ADP-AlF4 structure. The 2.5-mM AMPPNP and 10-mM ATP 
structures have nucleotide densities of intermediate amplitude (Figure 3). The nucleotide 
density in the 10-mM ATP structure is unambiguously more consistent with ATP than with 
ADP or ADP:Mg2+ (Figure 3C), suggesting that the low-twist filament segments used in the 
10-mM ATP reconstruction predominantly contained ATP that remained unhydrolyzed when 
the sample was frozen. The Hel1 and Hel2 domains are in the semi-closed state, as defined 
by (Uchikawa et al., 2016) in all structures except the ADP-AlF4-bound structure, which is in 
the closed state. Two out of six ATP-binding helicase motifs, motifs Q and I as defined by 
(Jiang et al., 2011), are engaged with nucleotide in the low-twist semi-closed structures. All 
six ATP-binding helicase motifs—motifs Q, I, II, III, Va, and VI—are engaged with ADP-AlF4 
in the closed structure. 
The asymmetric units of the three twist classes of filaments have a similar overall structure to 
the dsRNA-bound crystal structures of MDA5 (Figure S4). However, the cryoEM structures 
contain several features not present the crystal structures, most notably the C-terminal tail of 
the CTD (residues 1014-1020), which extends towards an adjacent subunit and forms key 
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filament contacts. The cryoEM structures also contain a short acidic loop in Hel1 (residues 
428-430), the linker between the pincer domain and the CTD (residues 894-899), and part of 
an extended loop within the central -sheet of the CTD (residues 945-949). Some of these 
features are present but have different conformations in the crystal and NMR structures of the 
MDA5 CTD alone (PDB 3GA3; Takahasi et al., 2009). The CARDs were not visible in any of 
the density maps after helical symmetry averaging, even at low contour levels, indicating that 
the CARDs do not share the helical symmetry of the MDA5-dsRNA filament. Since CARD 
oligomers could not be distinguished in the raw micrographs, we conclude that the oligomers 
are no larger than approximately 100 kDa, the current size limit for cryoEM single particle 
imaging, which corresponds to the tandem CARDs of six to eight MDA5 molecules. 
Identification of the filament forming interfaces 
The cryoEM structures identify the filament forming surfaces of MDA5. The majority of the 
contacts are hydrophobic and can be grouped into two interfaces, both involving the pincer 
domain (Figure 2). Interface I is formed by a loop in Hel1 (residues 395-408), which forms an 
extensive set of hydrophobic interactions with the first -helix of the pincer domain (residues 
839-864) and an adjacent loop in Hel1 (residues 497-500) of the adjacent subunit (Figure 2D 
and Movie S2). The most notable interactions are hydrophobic side chain contacts between 
Leu397, Ile399, Ser400, Glu403 and Val404 in Hel1, and Glu842, Ile845, Val846, Phe849, 
and Met853 in the pincer helix. These side chains form the core of interface I, with a buried 
surface area of 452 – 570 Å2 in the semi-closed structures and 413 Å2 in the closed ADP-AlF4-
bound structure. 
Interface II is formed by the C-terminal tail, which extends from the CTD to form hydrophobic 
contacts with the second pincer helix (residues 866-891) of the adjacent subunit (Figure 2C 
and Movie S3). The core contacts of the interface are hydrophobic side chain contacts 
between Asp1014, Tyr1015, Tyr1018 and Cys1019 in the C-terminal tail, along with Gly976 
and Leu977 in the CTD, and Gln879, Leu882, Glu883 and Met886 in the pincer domain. 
Glu883 also forms polar contacts with either Lys975 or Gly976, depending on the twist class. 
The C-terminal tail was not resolved in crystal structures of human and chicken MDA5 bound 
to dsRNA oligonucleotides, indicating that the structure of the C-terminal tail observed by 
cryoEM is dependent on head-to-tail intersubunit filament contacts. The surface area buried 
by interface II is 413 – 433 Å2 in the semi-closed structures and 471 Å2 in the ADP-AlF4-bound 
structure. Thus, whereas interface I buries a larger area than interface II in the semi-closed 
structures, the opposite is true in the closed ADP-AlF4 structure. 
The residues listed above as forming interfaces I and II are conserved or similar in MDA5 but 
not RIG-I sequences from vertebrate species (Figure S5). The following residues are strictly 
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conserved across terrestrial vertebrates in MDA5 but not RIG-I: 397-403, 497-500, and 846 in 
Interface I; and 879, 883, 886, 976, 977, 1015 and 1019 in Interface II. 
A minor filament contact point is formed by Met571 in Hel2i, which forms hydrophobic side 
chain contacts with Glu773 from the Hel2 domain of the adjacent subunit (Figure 5A). The 
contact area of this interface is small, 141 Å2 in Twist74, and only 42 – 65 Å2 in the higher-
twist classes, representing 4-13% of the total filament interface area. This interface is absent 
the ADP-AlF4-bound structure, and Met571 is not strictly conserved in mammalian MDA5 
sequences. 
Flexible MDA5 interfaces lead to variable helical symmetry 
The extent to which the MDA5 filament-forming interfaces are predominantly hydrophobic in 
nature is striking. Hydrophobic interfaces can be intrinsically structurally flexible and allow 
intersubunit rotation in the absence of the chemical and geometric restraints imposed by polar 
hydrogen bonds or salt bridges (Li et al., 2005). Comparison of the filament forming interfaces 
in the different twist classes shows that although the interfaces are broadly conserved, there 
are significant differences in how they form in each twist class. Superposition of the Twist74 
and Twist91 structures using the Hel1 domain of a specific subunit as the reference (Rmsd 
0.75 Å) highlights how variable and flexible the filament-forming interfaces are, with 
differences of up to 20 Å in the resulting positions of the domains of adjacent filament subunits 
(Figure 4). This large variability in the orientation of the adjacent subunits within the filament 
is possible specifically due to the structural versatility of the Hel1 loop component of Interface 
I (residues 395-408) and of the C-terminal tail component of Interface II (residues 1014-1020). 
These components have significantly different conformations in each twist class, each 
adapting their structure to maintain hydrophobic contacts with the apposed pincer domain 
helix from the adjacent subunit (Figures 4E-F and S6). The interface components within the 
pincer domain, constrained by helical secondary structure, have the same local conformation 
in the different twist classes, though the pincer helices, which pack tightly onto the Hel1 and 
Hel2 domains, follow the larger shifts in domain positions mentioned above. The specific 
hydrophobic contacts formed in the different twist classes are similar but not identical. For 
example, the C-terminal tail forms contacts two helical turns further down the second pincer 
helix in the Twist74 structure than in the Twist91 structure, and the Hel1 interface loop adopts 
a different conformation in Twist74 than in the other cryoEM and crystal structures (Movie S4). 
The net result is that the Hel1 interface loop functions as a flexible finger and the C-terminal 
tail as a flexible arm, allowing similar but not identical sets of hydrophobic contacts to be 
maintained between subunits. This bears similarity to the capsid proteins of some spherical 
viruses, which have flexible C-terminal arms and internal loops that allow the quasi-equivalent 
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assembly of capsomeres in slightly different symmetry environments within the icosahedral 
lattices of viral capsids (Liddington et al., 1991). 
Functional importance of MDA5 interfaces in cell signaling 
The filament interfaces are critical to MDA5 function because they encode the dsRNA binding 
cooperativity of MDA5 (Berke and Modis, 2012; Peisley et al., 2011). Hence the filament 
interfaces encode the propensity of MDA5 to form long filaments on RNA and signal more 
actively from longer dsRNAs. To test the functional importance of the filament forming 
interfaces revealed in our cryoEM structures, we examined the effect of structure-based 
mutations targeting the interfaces in cell signaling assays and filament forming assays. A panel 
of sixteen human MDA5 variants was generated, with each variant bearing one, two or three 
structure-based point mutations at one of the filament forming interfaces. Expression plasmids 
were individually co-transfected into HEK293 cells together with plasmids encoding firefly 
luciferase under control of the IFN-β promoter and Renilla luciferase under a constitutive 
promoter. After expression for 6 h, cells were transfected with polyI:C RNA to induce MDA5 
signaling. IFN-β-dependent induction of firefly luciferase was measured in cell lysates 24 h 
post-induction, as firefly luciferase luminescence normalized against Renilla luciferase 
luminescence (Figure 5). The expression level of each MDA5 variant in HEK cells was 
assessed by Western blotting (Figure 5C). With a few exceptions discussed below, the 
mutations significantly reduced or abolished luciferase signaling. The following mutations 
reduces luciferase activity down to background levels: L396A/K397A/I398A, in Hel1, and 
D848A/F849A, targeting other interface I contacts listed above (some residue numbers are 
different in human and mouse MDA5; Figure S5). Deletion of the C-terminal tail (∆C12) and 
CTD mutations K975D/D987A, targeting interface II contacts, resulted in a 4-fold reduction in 
signaling (Figure 5B). A triple point mutation in the C-terminal tail (D1014A/Y1015A/E1017K), 
also targeting interface II, caused a more modest 2- to 3-fold reduction in signaling (Figure 
S7B). T497A/K498A/Q499A, in interface I, resulted in a 2-fold reduction in luciferase activity. 
The M886A mutation caused a 30% reduction in signaling. The E883R/K884A and K885A 
mutations, targeting interface II contacts with the C-terminal tail and CTD, had no effect on 
signaling. 
The mutant I841R/E842R was shown previously to partially inhibit filament formation of human 
MDA5 on 1-kb dsRNA and to reduce binding affinity for 112-bp but not 15-bp dsRNA (Wu et 
al., 2013). This pair of mutations maps to the periphery of the pincer helix component of 
interface I, with Glu842 forming hydrophobic contacts with Thr395 or Leu397 in the Hel1 
interface loop. Ile841 does not form any interface contacts, however, and is not conserved in 
mouse and chicken MDA5. The I841R/E842R mutation resulted in a 2.5-fold reduction of 
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signaling, consistent with a moderate role of these residues, most likely Glu842, in filament 
formation (Figure 5B). The variant E402A/K405A/S406A had 77% of the signaling activity of 
WT MDA5, suggesting that the C-terminal portion of the Hel1 interface loop (residues 395-
408) plays only a minor role in filament formation (Figure S7B). 
Two variants unexpectedly caused slight increases in signaling activity: E875A and 
H871A/E875A (Figure S7B). His871 and Glu875 are in the second pincer helix, and their side 
chains form an intramolecular hydrogen bond in the Twist74 and Twist91 structures. The two 
residues form interface II contacts only in the Twist87 and Twist91 structures, with the C-
terminal tail of the adjacent subunit. Filaments formed by the E875A variant formed 
aggregates (Figure S7A). We speculate that the increase in signaling upon loss of this 
glutamate side chain, which is conserved in terrestrial vertebrates, may arise from the collapse 
of filaments into three-dimensional filamentous aggregates. 
To determine whether mutations in the MDA5 filament interfaces affected ATPase activity, we 
assayed the ATP hydrolysis activity of the mutants with reduced signaling activities. Mouse 
MDA5 variants L397A/K398A/I399A, T841R/E842R, D848K/D849A and ∆C12 had 
comparable activities to WT MDA5, ranging from 5.5 to 13 MATP MMDA5-1 s-1 (Figures 5D and 
6B). K498A/K499A/Q500A and K975D/D978A had no ATPase activity. However, the 
mutations in these variants are distant from the ATP binding site, and both mutants appeared 
to bind Mant-AMPPNP, a fluorescent ATP analog, with comparable affinity as WT MDA5 
(Figure S7E), although the equilibrium binding constants could not be determined due to 
limitations in protein solubility. In contrast, mutations in the nucleotide binding motifs reduce 
or abolish ATPase activity but increase signaling activity. For example, R337G, from a patient 
with elevated interferon and neuropathic symptoms, and G821S, which causes lupus-like 
autoimmune symptoms in mice, both constitutively activate MDA5 signaling in the absence of 
infection and abrogate ATPase activity (Funabiki et al., 2014; Rice et al., 2014). Similarly, 
R822Q, a common missense mutation in nucleotide binding motif VI, increases constitutive 
and RNA-stimulated signaling and is associated with Singleton-Merten syndrome (Rutsch et 
al., 2015). 
Interface mutations that impair signaling hinder polymerization 
Cell signaling data show that mutation of MDA5 filament forming residues predominantly 
results in loss interferon signaling activity. To determine whether these changes in signaling 
activity were due to corresponding changes in the efficiency of filament assembly, we purified 
fifteen mouse MDA5 mutants selected from the panel of human MDA5 mutants assayed for 
cell signaling. All variants were expressed in similar quantities as WT MDA5 and had similar 
solubilities and hydrodynamic radii consistent with a monodisperse monomeric population 
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(Figure S7C-D). We can therefore exclude the possibility that the loss of signaling activity 
observed in most interface mutants was due to gross destabilization of the protein fold. We 
then assessed the ability of each variant to assemble into filaments on 1 kb dsRNA in the 
presence of 1 mM AMPPNP, using filament formation in negatively stained electron 
micrographs as the readout (Figure 6A). We found a strong correlation between loss of 
signaling activity and loss of filament formation. Variants bearing mutations that completely 
abolished signaling or reduced signaling by at least fourfold (including K498A/K499A/Q500A, 
D848A/F849A, L397A/K398A/I399A, K975D/D987A and ∆C12) all failed to form filaments. 
D1014A/Y1015A/E1017A, which caused a 2.5-fold reduction in signaling also failed to form 
filaments. T841R E842R, which also caused a 2.5-fold reduction in signaling, formed filaments 
half as long as WT MDA5 (Figure S7A). Amongst the least impaired variants, E403A/K406A 
formed filaments that were 27% shorter that WT MDA5, correlating well with the 23% reduction 
of signaling observed for the related mutant E402A/K405A/S406A. 
To determine whether filament formation was strictly dependent on dsRNA, we imaged WT 
MDA5 and several of the mutants in the absence of dsRNA and with 1 mM AMPPNP. None 
of them formed filaments, including the hyperactive variant E875A, which remained 
monomeric in the absence of RNA (Figure S7C). In conclusion, mutation of MDA5 filament 
forming residues predominantly results in loss of cellular MDA5 signaling activity. Most 
mutations inhibit MDA5 filament formation and abolish cellular interferon signaling activity 
without significantly affecting ATPase activity. Two variants (K498A/K499A/Q500A and 
K975D/D978A) also lack ATPase activity. One pair of mutations (H871A/E875A) appears to 
increase signaling activity by promoting the collapse of filaments into filamentous aggregates. 
MDA5-RNA contacts and how they vary across the twist and nucleotide states 
The dsRNA binding interfaces vary in the different twist classes. The protein-RNA contact area 
decreases as twist increases, with 2,315 Å2 for Twist74, 2,102 Å2 for Twist87 and 1,926 Å2 for 
Twist91. The ADP-AlF4-bound structure, which has a twist of 88˚, has a protein-RNA interface 
of 2,152 Å2, similar to Twist87. The CTD forms stronger RNA contacts in the Twist74 structure 
than in the Twist91 structure (849 Å2 versus 471 Å2 contact areas), whereas the opposite is 
true for the Hel2i domain (293 Å2 versus 321 Å2). The intermediate-twist ADP-AlF4-bound 
structure is more similar to Twist74 in how its CTD and Hel2i domain bind RNA, with contact 
areas of 751 Å2 and 231 Å2, respectively. Within Hel2i, Gln581 is positioned in the Twist87 
and Twist91 structures to form hydrogen bonds with either or both bases of an RNA base pair. 
Within the CTD, Ile923, Glu924 and Met926 form hydrophobic contacts with the RNA 
backbone in the Twist74 structure; the side chain of His927 forms hydrogen bonds with the 
O2 or N2 atom of a pyrimidine base, and with the ribose hydroxyl group (the latter is present 
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in all three twist classes). The CTD capping loop (residues 944-953), so-called because it 
binds to RNA blunt ends in RIG-I and LGP2 (Li et al., 2009; Pippig et al., 2009; Wang et al., 
2010), is disordered in the Twist87 and Twist91 structures and in the MDA5-dsRNA crystal 
structures but partially ordered in the Twist74 structure, in which it forms contacts with the 
RNA backbone at the minor groove as had been predicted (Uchikawa et al., 2016). By contrast, 
in structures of the MDA5 CTD alone (PDB 3GA3; Takahasi et al., 2009) the capping loop and 
flanking residues 947-953 extend the central -sheet of the CTD, forming an additional pair of 
-strands. The resulting conformation is incompatible with dsRNA binding, suggesting that 
dsRNA binding causes the capping loop to peel off from the central -sheet. 
There is less variation across the cryoEM structures in the number of RNA contacts formed 
by the helicase motifs. Eight out of the ten RNA-binding helicase motifs are engaged with the 
RNA (motifs Ia, Ib, Ic, IIa, IV, IVa, V and Vc, as defined by (Jiang et al., 2011), with IVb and 
Vb not engaged). Hel2 forms a more extensive set of contacts than Hel1, with contact areas 
of 565-660 Å2 for Hel2 versus 492-502 Å2 for Hel1. Many of the Hel2-RNA contacts are formed 
by the Hel2 loop (residues 758-767, adjacent to motif IVa), identified previously as a key 
element for dsRNA stem recognition by inserting into the major groove (Wu et al., 2013). This 
loop has a similar conformation in the cryoEM and crystal structures (Uchikawa et al., 2016; 
Wu et al., 2013), and insertion of the loop into the RNA major groove causes a similar widening 
of the groove from 12 Å to 16 Å. The groove is widened further, to 18 Å, in the ADP-AlF4-
bound structure. Moreover, in the Twist74 and ADP-AlF4-bound structures, His759, at the 
apex of the Hel2 loop, is positioned so that it could form a hydrogen bond with the O4 or N4 
atom of a pyrimidine base. The analogous residue in chicken MDA5 (His733) forms a 
hydrogen bond with an RNA base, albeit with a purine (G), in a crystal structure in complex 
with ADP:Mg2+ (Uchikawa et al., 2016). In contrast, in the Twist87 and Twist91 structures the 
Hel2 loop does not form any base contacts and is less firmly engaged with the RNA major 
groove. Previous work has shown that the Hel2 loop is required for dsRNA-dependent ATP 
hydrolysis by MDA5 (Wu et al., 2013). Hence, our data support the hypothesis that ATP 
binding and progression of catalysis to the transition state promote progressive insertion of 
the Hel2 loop into the RNA major groove, causing a widening of the groove (Figure 7B and 
Movie S5). Consistent with this, the dsRNA is slightly stretched along its helical axis in the 
cryoEM structures relative to free dsRNA (Pabit et al., 2016), and the increase in the rise per 
bp over the asymmetric unit versus free dsRNA is 13% in the ADP-AlF4-bound structure versus 
only 8% in the Twist87 structure, which has very low nucleotide occupancy in the active site. 
ATP hydrolysis causes Hel1-Hel2 rotation, increasing RNA footprint and filament twist 
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The structure of MDA5-dsRNA filaments bound to the catalytic transition state analog ADP-
AlF4 captures a key intermediate in the ATPase cycle. The Hel1 and Hel2 domains are in the 
fully closed state, with all six nucleotide binding motifs correctly positioned for catalysis. The 
configuration of the helicase and pincer domains is similar to those in the closed structures of 
RIG-I and LGP2 bound to ADP-AlF4 (Kowalinski et al., 2011; Uchikawa et al., 2016). 
Superposition of the ATP- and ADP-AlF4-bound MDA5 structures via Hel1 shows that, as in 
RIG-I and LGP2, the transition from the semi-closed state to the closed state involves a 6 – 7˚ 
rotation of Hel2 relative to Hel1, which brings nucleotide binding motifs Va and VI in Hel2 into 
position for catalysis (Figure 7A, Figure360 and Movie S5). This rotation of Hel2 relative to 
Hel1 is transduced by the pincer domain and is part of the conserved allosteric mechanism 
coupling ATP hydrolysis to dsRNA binding in RLRs (Rawling et al., 2014). As in LGP2 
(Uchikawa et al., 2016), the transition from the semi-closed ATP-bound state to the closed 
ADP-AlF4-bound state is accompanied by a shift in the interactions with the RNA backbone 
made by Hel2 (via motifs IVa and V) by one phosphate along the backbone in the 3’ direction, 
whereas the interactions of Hel1 with the RNA (via motifs Ia, Ib, Ic, and IIa) are unchanged. 
The net effect of this shift in Hel2-RNA backbone interactions is a 1-bp increase in the overall 
footprint of MDA5, from 14 bp in the ATP-bound state to 15 bp in the transition state. Hence, 
progression from the catalytic ground state (semi-closed, ATP-bound) to the transition state 
(closed, ADP-AlF4-bound) induces a rotation of Hel2 relative to Hel1 that increases the RNA 
binding footprint by 1 bp. We conclude that ATP hydrolysis by MDA5 is directly coupled to a 
1-bp increase in RNA binding footprint. 
Along with the increase in RNA binding footprint, the rotation of Hel2 relative to Hel1 upon 
ATP hydrolysis causes a shift in the position of the RNA backbone at the Hel2 contact site in 
the direction of the Hel2 rotation. As noted above, the Hel2 loop forms many of the Hel2-RNA 
contacts, inserts into the RNA major groove and causes widening of the groove. The extent of 
the widening is greater in the transition state, which contributes to the shift in RNA backbone 
position relative to the ground state. The net shift of the RNA backbone in the transition state 
suggests that ATP hydrolysis causes a local distortion of the RNA at the Hel2 loop contact site 
(Figure 7B, Movies S1-S5). Consistent with this, in the mid- and high-twist semi-closed 
structures (Twist87 and Twist91) the Hel2 loop is less firmly engaged with the RNA major 
groove, the RNA backbone is in a similar position as in the ground state (Figure 7B), and the 
overall helical rise is reduced by 2 Å relative to the transition state (Table 1). Hence the RNA 
is less distorted in the low nucleotide-occupancy Twist87 structure than in the transition state, 
which has the same twist. This suggests that the strain introduced in the RNA in the transition 
state dissipates upon dissociation of the nucleotide and relaxation of the Hel1-Hel2 interface 
back to the semi-closed state. Notably, the Hel2-RNA backbone interactions of the Twist87 
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and Twist91 structures are in the same register as in the ground state structure (Twist74) 
despite having the same 15-bp footprint as the transition state structure. This suggests that 
the increases in RNA binding footprint and helical twist gained upon ATP hydrolysis are 
maintained after dissociation of the nucleotide. 
In contrast to LGP2 and RIG-I, the conformational change from the ATP-bound ground state 
to the ADP-AlF4-bound transition state is coupled to shifts in both the Hel2i and CTD domains 
such that the transition state structure wraps more tightly around the dsRNA, reducing the gap 
between Hel1 and the CTD by approximately 5 Å (Figure 7C). This slightly tighter winding of 
MDA5 around the RNA could generate overwinding of the RNA, which could explain the 
increase in helical twist that occurs in going from the ground state to the transition state. 
Discussion 
The dsRNA binding cooperativity and length specificity of MDA5, which are critical for its 
signaling activity, are encoded by the filament-forming interfaces. The cryoEM structures of 
MDA5-dsRNA filaments determined in this study identify two filament forming surfaces, 
providing an essential missing link to understanding the polymerization-dependent recognition 
of dsRNA by MDA5 at the molecular level. The predominantly hydrophobic nature of the 
filament-forming contacts provides the flexibility necessary to support cooperative filament 
assembly on inherently flexible dsRNA. We have shown that mutation of filament forming 
residues results in loss of filament formation and MDA5-dependent signaling, with the 
exception of a pair of mutations, which moderately enhances signaling. In a clinical setting, 
increased interferon signaling from mutations that stabilize the filament forming interfaces has 
potential to be pathogenic. Indeed, many gain-of-function mutations in MDA5 cause severe 
autoimmune disease (Ahmad et al., 2018; Rice et al., 2014; Rutsch et al., 2015), although the 
disease-associated mutations reported so far map to the RNA and ATP binding sites. Hence 
the identification of the filament forming interface has predictive value for researchers and also 
for clinicians who are likely to encounter patients with SNPs in the filament forming regions of 
MDA5. 
Structural changes in MDA5-dsRNA filaments coupled with ATP binding and hydrolysis 
A comparative analysis of cryoEM structures determined in the presence of different ATP 
nucleotide analogs reveals clear correlations between the type and occupancy of the 
nucleotide bound in the catalytic site, the length of the RNA binding footprint and the helical 
twist of the filaments. Filaments formed with transition state analog ADP-AlF4 had a narrow 
distribution of intermediate twists (81˚ – 91˚) and a 15-bp footprint, whereas filaments formed 
with a high concentration of ATP (10 mM) had mostly low helical twist (71˚ – 81˚) and a 14-bp 
footprint (Figure 1C). In both of these cases the nucleotide occupancy in the active site was 
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high (Figure 3). Filaments formed with lower concentrations of the nonhydrolyzable ATP 
analog AMPPNP (1 – 2.5 mM) had a broad range of twists (71˚ – 96˚) and 15-bp footprints. 
Within these populations, the low-twist filaments had relatively high AMPPNP occupancy in 
the active site, but the filaments with intermediate and high twists had very little, if any 
nucleotide in the active site. The lack of AMPPNP density in these twist classes is not 
surprizing as the AMPPNP concentration present in the samples was of the same order of 
magnitude as the Km for ATP reported for chicken MDA5 bound to a 24-bp dsRNA (2.2 ± 0.47 
mM; Uchikawa et al., 2016). Although the Km(ATP) is likely to be smaller for MDA5 filaments 
on long dsRNAs, if we assume a Kd(AMPPNP) value of 1 mM, the occupancy of AMPPNP in 
the catalytic site can be expected to be 30-50% given the concentration of MDA5 in the imaged 
samples (3.45 µM). This would imply that less than half of the imaged MDA5 molecules 
contained AMPPNP in their active site. Consistent with this, more than half the filaments 
segments formed with 1 – 2.5 mM AMPPNP had intermediate or high twist, lacked AMPPNP 
density in the active site, and had essentially identical structures as segments formed without 
nucleotide (Figure 1). We conclude that ATP binding and hydrolysis are coupled to increases 
in the helical twist and RNA binding footprint of the filament. 
Together, our structural data support the hypothesis that our cryoEM reconstructions have 
captured three distinct intermediates in the ATPase cycle. The low-twist structures correspond 
to the ATP-bound catalytic ground state, the intermediate-twist ADP-AlF4-bound structure is 
the transition state, and intermediate- and high-twist states that represent nucleotide-free 
states (Figure 7D). The coincidence of all three twist states on the same filament (Figure 1B) 
therefore suggests that multiple nucleotide binding states can coexist on one filament. The 
RecA-like domains Hel1 and Hel2 are in the closed conformation in the transition state and in 
the semi-closed conformation in the other states. The RNA binding footprint is 14 bp in the 
ground state and expands to 15 bp in the transition and nucleotide-free states. Notably, the 
increased twist and RNA footprint are maintained in the low nucleotide-occupancy states, even 
though the helicase domains return to the semi-closed state. Despite the increase in RNA 
footprint, the protein-RNA contact area decreases as the catalytic cycle proceeds, from 2,300 
Å2 in the ground state to 2,100 Å2 in the intermediate-twist states and 1,900 Å2 in the high-
twist nucleotide-free state. This implies that dissociation of ADP and Pi following hydrolysis 
causes MDA5 to loosen its grip on the RNA. Indeed, Uchikawa et al. (2016) reached the same 
conclusion based on the crystal structures of MDA5 and LGP2 bound to dsRNA and different 
nucleotide analogs. Consistent with this, MDA5 forms longer, more continuous filaments in 
the presence of nonhydrolyzable ATP analogs than without nucleotide (Berke et al., 2012; 
Peisley et al., 2012; Wu et al., 2013). In contrast, binding of ATP or transition state analogs to 
RIG-I reduces its affinity for RNA (Rawling et al., 2015). 
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Potential role of ATP hydrolysis in MDA5 function 
The structural snapshots of the ATPase cycle we have obtained provide clues on the potential 
role of ATP binding and hydrolysis in MDA5 signaling, though open questions remain. The 
ATPase cycle of RIG-I and MDA5 has been proposed to perform a proofreading function in 
discrimination of self- versus non-self dsRNA by increasing the rate of dissociation of the 
protein from shorter endogenous RNAs (Lassig et al., 2015; Peisley et al., 2012; Rawling et 
al., 2015). In the case of RIG-I, ATP binding (Rawling et al., 2015) and hydrolysis (Lassig et 
al., 2015) have both been reported to promote dissociation from non-cognate RNA ligands. In 
the case of MDA5, ATP hydrolysis was found to enhance the binding specificity for long 
dsRNAs and promote formation of more continuous and stable filaments, while promoting 
dissociation from shorter dsRNAs (Peisley et al., 2012). As noted above, our structures show 
that binding of MDA5 induces significant distortions in the dsRNA backbone. The extent and 
location of these distortions vary in the different intermediates of the ATPase cycle (Movie 
S5). A possible interpretation is that ATP hydrolysis by MDA5 tests the physical properties of 
the RNA—specifically resistance to twisting and bending—such that MDA5 is more likely to 
remain associated with cognate ligands (exogenous long continuous RNA duplexes) and more 
likely to dissociate from non-cognate ligands (deaminated Alu repeats and short endogenous 
RNAs) due to the different way each type of ligand responds to the ATP-dependent 
conformational changes in MDA5, including changes in helical twist. This would provide a 
mechanical proofreading mechanism dependent on ATP hydrolysis. Consistent with this 
hypothesis, biochemical studies suggest that ATP binding contributes to proofreading by RIG-
I by challenging the interaction with RNA and promoting dissociation (Rawling et al., 2015). 
Our structural data indicate that ATP hydrolysis is coupled with a 1-bp expansion in the dsRNA 
binding footprint through ratchet-like movements of Hel2 relative to Hel1 (Figure 7B). This 
could in principle result in translocation of dsRNA. However, translocation would require 
cooperative binding of ATP to adjacent protomers and sequential hydrolysis in one direction 
along the filament. It appears more likely that expansion of the RNA binding footprint is a local 
phenomenon. Local expansion of the MDA5 footprint would provide a possible explanation for 
the reported repair of MDA5 filament discontinuities through ATP hydrolysis (Peisley et al., 
2012). Expansion of the binding footprint of a long continuous filament could also explain how 
MDA5 can displace viral proteins from dsRNA in an ATP-dependent, CARD-independent 
manner (Yao et al., 2015). Further work is required to determine more specifically how ATP 
hydrolysis propagates structural changes through MDA5-dsRNA filaments and how these 
changes may contribute to the proofreading and antiviral effector functions of MDA5. 
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Figure Legends 
Figure 1 
CryoEM image reconstruction of MDA5-dsRNA filaments with helical symmetry averaging. 
See also Figures S1 and S2. 
(A) Representative cryoEM micrograph of MDA5-dsRNA filaments. 
(B) CryoEM micrograph shown in (A) with circles drawn around the boxed filament segments 
that were used in the helical reconstructions. The circles are colored according to the 3D class 
that they contributed to. Segments that contributed to the Twist74, Twist87 and Twist91 
structures are in red, green and blue, respectively. 
(C) Histogram showing the distributions of filament segments as a function of helical twist for 
the ATP, ADP-AlF4, 1-mM AMPPNP and nucleotide-free datasets. The distributions shown 
are from 3D classification performed with ten classes per dataset. Error bars represent 
standard error of the mean between replicate 3D classification calculations; n = 3. 
(D) 3D density map of the Twist74 MDA5-dsRNA filament at 3.68 Å overall resolution. The 
components are colored as follows: Hel1, green; Hel2, cyan; Hel2i, yellow; pincer domain, red; 
CTD, orange; RNA, magenta. 
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(E) The dsRNA density in the Twist74 filament (blue mesh) is shown with the fitted atomic 
model (magenta, pink). 
Figure 2 
Atomic model of the MDA5-dsRNA filament. See also Figure S3 and Movies S1-S5. 
(A) Domain structure of mouse MDA5. CARD, caspase recruitment domain; Hel1 and Hel2, 
first and second RecA-like helicase domains; Hel2i, Hel2 insert domain; P, pincer domain; 
CTD, C-terminal domain. The same color code and domain abbreviations are used in 
subsequent panels and in Figures 1, 7A and 7D. 
(B) Overview of the refined atomic model of the MDA5-dsRNA filament. Two adjacent MDA5 
subunits and 28 bp of dsRNA are shown from the Twist74 structure. RNA is in magenta. The 
bound AMPPNP molecules are shown in sphere representation. The two filament forming 
interfaces are boxed. 
(C and D) Close-up views of filament Interface II (C), and Interface I (D). The top panels show 
side chains forming key contacts, with hydrogen bonds shown as yellow dashed lines. In the 
middle panels the lower protomer in (B) is shown in surface representation colored by 
hydrophobicity from grey to green, with green being the most hydrophobic. In the lower panels, 
the upper protomer in (B) is shown in surface representation colored by hydrophobicity. The 
orientation of the view relative to (B) is indicated for each panel. 
Figure 3 
Close-up views of the cryoEM densities and atomic models around the ATP binding site for 
reconstructions with different helical twists and bound nucleotides. See also Figure S3.  
A contour level of 4.5  in PyMol was used for all panels. The AMPPNP, ATP and ADP-AlF4 
molecules, and selected protein side chains are shown in stick representation. Density 
consistent with a nucleotide triphosphate molecule is visible in the low-twist structures with 2.5 
mM AMPPNP (B) and 10 mM ATP (C), but only weak density is visible in the low twist (74˚) 1 
mM-AMPPNP structure (A) (red outline). With 2 mM ADP-AlF4 (D) strong density is visible for 
the ADP and AlF4 moieties (green box). The AlF4 moiety shown in pink and grey and a 
coordinated Mg2+ ion in cyan. With 1 – 2.5 mM AMPPNP or no nucleotide (E-H) there is no 
nucleotide density in the catalytic site of the structures with mid- to high helical twist (81 – 96˚, 
blue box). 
Figure 4 
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Differences in relative domain positions and filament contacts in the Twist74 and Twist91 
structures. See also Figures S4-S6 and Movies S1-S5. 
(A) Overview of two protomers of the Twist74 and Twist91 structures superimposed using the 
pincer domain of the lower protomer (grey) as the reference. The upper protomer of Twist74 
is in blue and that of Twist91 is in brown. 
(B and C) Top views along the helical axis of the upper protomer from panel (A) showing the 
shifts in the positions of Hel2i and CTD (B), and Hel1, Hel2 and pincer (C). The 20 Å translation 
in Hel2i and 12˚ rotation in the pincer domain are highlighted. The highlighted domains are 
colored as in the upper protomer in (A) and the remaining domains are shown in transparent 
grey for clarity. The outer contour of the superimposed structures is shown for reference as a 
black outline. 
(D) Close-up of the dsRNAs from the Twist74 and Twist91 structures from the structural 
alignment in panel (A). The Rmsd of the atoms in the 14 superimposed RNA base pairs is 
1.23 Å. 
(E and F) Close-up views of filament interface I (E) and interface II (F). The protomer of 
Twist74 shown in grey in (A) and used as the alignment reference is shown in surface 
representation colored by hydrophobicity as in Figure 2. Key interface residues in the adjacent 
protomer are shown with Twist74 in blue and Twist91 in brown. 
Figure 5 
Mutations at the filament forming interfaces abolish or reduce cell signaling in response to 
dsRNA. See also Figure S7. 
(A) Location of the engineered filament interface mutations. Two filament protomers are 
shown in surface representation with the filament forming surfaces of each protomer colored 
in red and blue, respectively. The protomers are shown assembled with the helical axis 
horizontal (top); and separately after being opened like a book with 90˚ rotations in opposite 
directions to show the interface surfaces (bottom). Residue labels are colored pink for interface 
I and green for interface II. Residue numbers refer to mouse MDA5. 
(B) IFN-β reporter cell signaling assay. Plasmids encoding human MDA5 mutants were co-
transfected into HEK293 cells with plasmids encoding firefly luciferase under an IFN-β-
inducible promoter and Renilla luciferase under a constitutive promoter. Cells were later 
transfected with polyI:C RNA (+PolyI:C) or DMEM (-PolyI:C). Relative luciferase activity was 
calculated as the ratio of firefly to Renilla luciferase luminescence. Residue numbers refer to 
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human MDA5. Error bars represent standard error of the mean between measurements; n = 
3. 
(C) Western blots showing the expression level of the human MDA5 mutants in HEK293T 
cells. The FLAG tag on each MDA5 variant was detected with an anti-FLAG antibody. 
(D) ATP hydrolysis assay. The ATPase activities of MDA5 mutants with reduced signaling 
activity were measured as release of inorganic phosphate (Pi) on incubation with ATP and 1-
kb dsRNA. Error bars represent standard error of the mean; n = 3. 
Figure 6 
Interface mutations that impair signaling also impair filament formation. See also Figures S5 
and S7. 
(A) Representative electron micrographs of MDA5 filament interface mutants in the presence 
of 1 kb dsRNA, 1 mM AMPPNP and 5 mM MgCl2. Scale bars are 100 nm. Residue numbers 
refer to mouse MDA5. 
(B) Table summarizing the filament formation activity, filament length, cell signaling activity, 
and ATPase activity of selected MDA5 mutants. ATPase activities were calculated from the 
initial slopes of the curves in Figure 5D and is expressed as moles of released phosphate per 
mole of MDA5 per second, MPi MMDA5-1 s-1. 
Residue numbers refer to mouse MDA5. For mutants with different residue numbers in human 
MDA5, the corresponding mutation is shown in human residue numbers at the bottom. N.d., 
not determined. 
Figure 7 
Comparison of the closed ADP-AlF4-bound structure with the semi-open structures and 
schematic model of the ATPase cycle and proofreading mechanism of MDA5. See also 
Figure360 and Movies S1-S5. 
(A) Close-up view of the nucleotide binding site and Hel1-Hel2 domain interface. The Twist74 
AMPPNP-bound structure (blue) was superimposed on the ADP-AlF4-bound structure 
(colored by domain as in Figure 2) using the Hel1 domain as the reference. Nucleotide binding 
motifs Va and VI are labeled. Only the ADP-AlF4 nucleotide is shown, for clarity. 
(B) Close-up view of the Hel2-loop and its interactions with the dsRNA. The Twist74 (blue) 
and Twist87 (pink) AMPPNP-bound structures are superimposed onto the ADP-AlF4-bound 
structure (green) using Hel1 as the reference. 
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(C) Overview of Twist74 (blue) superimposed on the ADP-AlF4-bound structure (green) using 
Hel1 as the reference. 
(D) Model of the ATPase cycle and proofreading mechanism. Only two filament protomers are 
shown for clarity. The low-twist (71 – 81˚) structures correspond to the ATP-bound catalytic 
ground state, the intermediate-twist (81 – 91˚) ADP-AlF4-bound structure is the transition state, 
and the intermediate- and high-twist (91 – 96˚) states represent nucleotide-free states. The 
four panels relate to the panels in Figure 3C-F.  
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Table 1. CryoEM data collection, structure determination, model building and refinement 
parameters and statistics. See also Figures 1, 3 and S2, S3. 
  
Mouse MDA5 bound to Phi6 dsRNA   
1 mM AMPPNP 
MDA5-dsRNA, 
2.5 mM AMPPNP  
MDA5-dsRNA, 
10 mM ATP 
MDA5-dsRNA,  
2 mM ADP-AlF4 
MDA5-dsRNA,  
No nucleotide 
Data Collection and Processing        
Microscope FEI Titan Krios FEI Titan Krios FEI Titan Krios FEI Titan Krios FEI Titan Krios 
Voltage (kV) 300 300 300 300 300 
Electron exposure (electrons Å-2) 29.85 29.33 30.24 29.85 / 30.50 27.0 
Exposure per frame (electrons Å-2) 0.398 0.391 0.403 0.398 / 0.272 1.00 
Defocus range (µm) -1.8 – -2.7 -1.8 – -2.7 -1.7 – -3.1 -1.8 – -2.7 -1.8 – -2.7 
Pixel size (Å) 1.07 1.07 1.07 1.07 / 1.085 1.04 
N. initial segment images 367,549 207,000 526,596 234,835 137,601 
 
3D class average 
 
Twist74 
 
Twist87 
 
Twist91 
 
Twist77-2.5  
 
Twist72-10 
 
ADP-AlF4 
 
Tw89-NoNt 
 
Tw93-NoNt 
N. final segment images   33,138 60,079 40,265 28,663 100,482 31,556 26,527 19,111 
Map resolution range (Å) 240 – 3.68 240 – 3.93 240 – 3.93 240 – 4.06 240 – 3.87 240 – 4.06 240 – 4.02 240 – 4.16 
FSC threshold for resolution limit 0.143  0.143 0.143 0.143 0.143 0.143 0.143 0.143 
Max. local resolution range 24.0 – 3.42 20.0 – 3.63 20.0 – 3.69 26.6 – 3.63 21.8 – 3.58 26.6 – 3.99 50.0 – 3.22 50.06 – 3.89 
 
Model refinement 
       
 
Map sharpening B factor (Å2)
 
 -175 -165 -175 -125 -175 -175 -150 -175 
Helical symmetry imposed          
  Twist (˚) 74.302 87.369 90.921 76.776 72.817 87.832 89.000 93.060  
  Rise (Å) 42.844 44.510 44.970 43.106 43.062 46.511 44.242 44.366 
Mask correlation coefficient 0.767 0.767 0.762 0.795 0.818 0.798 0.801 0.775 
         
Model composition         
N. non-hydrogen atoms 6,209 5,894 5,907 6,209 6,268 6,296 5,955 5,997 
Protein residues 682 645 648 682 689 685 660 667 
RNA nucleotides 28 30 30 28 28 30 30 30 
Ligand AMPPMP – – AMPPMP ATP ADP-AlF4 – – 
Ions (Zn2+, or Zn2+ and Mg2+) 1 1 1 1 2 1 1 1 
         
R.m.s. deviations         
Bond lengths (Å) 0.012 0.006 0.010 0.011 0.007 0.006 0.007 0.008 
Bond angles (˚) 1.093 1.000 1.242 1.050 0.896 0.938 0.820 0.872 
Planarity (Å) 0.006 0.004 0.005 0.006 0.004 0.004 0.005 0.006 
         
B-factors/ADPs*         
Minimum 30.0 54.4 51.0 102 75.6 57.9 76.1 36.8 
Maximum 100 170 156 263 187 159 198 145 
Mean 56.0 103 100 167 115 95.4 136 78.8 
          
Validation         
MolProbity overall score 1.71 1.79 1.83 1.77 1.65 1.74 1.71 1.76 
MolProbity all-atom clashscore 3.52 3.84 4.37 4.00 3.09 4.03 3.87 4.19 
Rotamer outliers (%) 0 0 0 0 0.11 0 0.18 0.17 
Ramachandran plot         
  % favored 89.4 87.3 87.3 88.8 90.1 90.0 90.5 89.5 
  % allowed 10.3 12.7 12.7 10.9 9.7 10.0 9.5 10.3 
  % outliers 0.3 0 0 0.3 0.2 0 0 0.2 
PDB codes 6G19 6G1S 6G1X 6GJZ 6GKM 6GKH 6H61 6H66 
EMDB codes 4338 4340 4341 0012 0024 0023 0143 0145 
EMPIAR codes 10213 10213 10213 10209 10208 10211 10210 10210 
*ADPs, atomic displacement parameters. 
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STAR ★ Methods 
 
CONTACT FOR REAGENT AND RESOURCE SHARING  
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Yorgo Modis (ymodis@mrc-lmb.cam.ac.uk) 
 
EXPERIMENTAL MODEL DETAILS  
Cell lines 
 HEK293T cells were a kind gift from Yiquan Tang in William Schafer’s group (MRC 
Laboratory of Molecular Biology).  
Microbe strains 
All proteins were expressed in Escherichia coli BL21(DE3) cells (Merck). 
 
METHOD DETAILS 
Protein expression and purification of MDA5 
Genes encoding mouse MDA5 (IFIH1) were cloned in frame with the N-terminal histidine 
purification tag of a pET28a vector in which the thrombin cleavage site was replaced with a 
tobacco etch virus (TEV) protease cleavage site. Wild-type (WT) mouse MDA5 with residues 
646–663 deleted, MDA5-∆L2, was expressed from a previously generated pET28a expression 
plasmid (Berke and Modis, 2012). The ∆L2 loop deletion is in a solvent exposed loop of Hel2i. 
The deleted sequence is not conserved in other vertebrate MDA5 genes (Figure S5). Its 
deletion does not affect the dsRNA binding, ATPase or interferon signaling activities of MDA5 
(see (Berke et al., 2012; Wu et al., 2013), in supplementary information). Mouse MDA5-∆L2 
mutants were cloned into the pCold vector with an N-terminal extension comprising a 
hexahistidine tag, maltose binding protein (MBP) and human rhinovirus (HRV) 3C protease 
cleavage site or pET28a vector in which the thrombin cleavage site was replaced with a TEV 
protease cleavage site. 
Escherichia coli BL21(DE3) cells were transformed with an MDA5 construct and grown to 
OD600 0.4-0.5 at 37˚C. After cooling for 15 min at 16˚C, expression was induced overnight with 
0.4 mM isopropyl--D-1-thiogalactopyranoside (IPTG). Harvested cells were resuspended in 
SPG buffer pH 6.0 (49 mM NaH2PO4, 49 mM glycine, 14 mM succinic acid), 0.4 M KCl, 5 mM 
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-mercaptoethanol, 5% glycerol, 20 mM imidazole. Roche Complete Protease Inhibitor 
(without EDTA), 0.2 mM phenylmethanesulfonylfluoride (PMSF) and 1 µg ml-1 pepstatin A 
were added immediately prior to cell lysis. 
MDA5-ΔL2 protein was purified with three liquid chromatography steps: nickel-affinity with Ni-
NTA agarose (QIAGEN), anion-exchange with a HiTrapQ or ResourceQ column (GE 
Healthcare), and size-exclusion with a Superdex 200 Increase 10/300 GL column (GE 
Healthcare). The protein used for nucleotide-free MDA5-dsRNA data collection was treated 
with 0.5 mM EDTA for 1 h to remove nucleotide before loading on a Superdex 200 Increase 
10/300 GL column. The MBP-tagged mutants were purified by with the same procedure except 
that on-column cleavage with HRV 3C protease in a HEPES pH 7.0 buffer was used to elute 
the proteins from the Ni-NTA agarose beads. 
Extraction and in vitro transcription of double-stranded RNA 
Bacteriophage Φ6 genomic dsRNA was purchased from ThermoFisher. The 1 kb dsRNA was 
prepared by T7 in vitro transcription using T7 RNA Polymerase (New England Biolabs) 
following to the manufacturer’s instructions. Two complementary strands were co-transcribed. 
The transcripts were treated with DNase and purified by column-based purification 
(ThermoFisher PureLink RNA Mini Kit). After purification transcripts were heated at 95˚C for 
5 min then annealing by cooling to room temperature. 
Negative stain EM  
For the filament assembly assay, 26 µg ml-1 MDA5-∆L2 or MDA5-∆L2 mutants were incubated 
with 3.24 µg ml-1 of 1 kb dsRNA in buffer containing 20 mM HEPES pH 7.7, 0.1 M KCl, 5 mM 
MgCl2, 1 mM AMPPNP on ice for 30 min. Samples were applied to glow-discharged carbon-
coated grids, negatively stained with uranyl acetate [2% (wt/vol)], and imaged with an FEI 
Tecnai 12 transmission electron microscope at an accelerating voltage of 120 kV. Images 
were taken at 3 - 4 µm defocus, 26000 magnification and with 4 Å per pixel. The length of 
filaments was measured manually with ImageJ.  
CryoEM sample preparation and data collection 
WT MDA5-ΔL2 at a concentration of 0.8 g l-1 was incubated with 0.03 g l-1 bacteriophage Φ6 
dsRNA (ThermoFisher) in buffer containing 20 mM HEPES pH 7.7, 0.1 M KCl, 5 mM MgCl2, 
2 mM DTT and 1 mM AMPPNP on ice for 30 min. CryoEM grids were prepared with a Vitrobot 
(ThermoFisher) at 4°C at 100% humidity. Filament samples were diluted twofold with buffer 
(20 mM HEPES pH 7.7, 0.1 M KCl, 5 mM MgCl2, 2 mM DTT) and a 3.5 µl aliquot of the sample 
was immediately applied onto a glow-discharged 300-mesh gold Quantifoil R1.2/1.3 grid 
(Quantifoil Micro Tools). For the 2.5 mM AMPPNP filament sample, 1 g l-1 protein was 
 28 
incubated with 0.05 g l-1 1-kb dsRNA and 2.5 mM AMPPNP on ice for 5 – 10 min. For the 10 
mM ATP filament sample, 1 g l-1 protein was incubated with 0.05 g l-1 1-kb dsRNA and 10 mM 
ATP for 7.5 min. For the 2 mM ADP-AlF4 filament sample, 1 g l-1 protein was incubated with 
0.05 g l-1 1-kb dsRNA, 2 mM ADP, 4 mM AlCl3 and 40 mM NaF for 2 h. For the nucleotide-free 
MDA5-dsRNA filament sample, 1 g l-1 protein (EDTA-treated during purification) was 
incubated with 0.05 g l-1 1-kb dsRNA. The grids were blotted for 4 s and plunge-frozen in liquid 
ethane cooled by liquid nitrogen in the Vitrobot. CryoEM data collection was performed on a 
Titan Krios microscope operated at 300 kV equipped with Falcon III direct electron detector in 
counting mode (ThermoFisher). For the 1-mM AMPPNP dataset, a total of 1,563 micrographs 
from 3 independent sessions were recorded at a calibrated magnification of 75000 leading 
to a magnified pixel size of 1.07 Å. Each movie comprises 75 sub frames with a total dose of 
29.85 e- Å-2, exposure time 60 s and a dose rate 0.57 e- pixel-1 second-2 on the detector. Data 
acquisition was performed with EPU Automated Data Acquisition Software for Single Particle 
Analysis (ThermoFisher) with one shot per hole at -1.8 µm to -2.7 µm defocus. For the 2.5-
mM AMPPNP, 2-mM ADP-AlF4 10-mM ATP, and nucleotide-free samples, the datasets were 
collected as described for the 1-mM AMPPNP sample except with minor variation of dose and 
pixel size due to the use of different microscopes. 
Image processing and helical reconstruction 
All movies were motion-corrected and dose-weighted with MOTIONCOR2 (Zheng et al., 2017). 
Aligned, non-dose-weighted micrographs were then used to estimate the contrast transfer 
function (CTF) with GCTF (Zhang, 2016). All subsequent image processing steps were 
performed using helical reconstruction in RELION 2.1.0 (He and Scheres, 2017; Scheres, 
2012). Approximately 4,100 segments were manually picked in RELION. One round of 
reference-free two-dimensional (2D) classification was performed to produce templates for 
reference-dependent auto-picking. A limited resolution E-step (low-pass filter) of 15 Å was 
applied to prevent overfitting. Using the resulting 2D classes as templates, overlapping helical 
filament segments were automatically picked with an inter-box distance of 44 Å, to coincide 
with the helical rise measured from the power spectra. 
With the first 891-movie dataset collected on the Krios microscope, reconstructions with a box 
size of 400, 320, 256, 224 or 192 pixels were compared. A cylinder with a 12 nm diameter 
was used as the initial model. A spherical mask with a diameter equal to 90% of the box size 
was applied. Selected 2D classes were used with the cylindrical initial model to perform 3D 
auto-refinement in RELION using the helical rise measured from the power spectra (44 Å) and 
the twist derived from the negative-stain EM structure (Berke et al., 2012) (74˚ - 93˚). RELION 
reduces blurring effects from variability of helical symmetry between filament segments by 
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only using the central part of an intermediate asymmetrical reconstruction for real-space 
helical symmetrization (He and Scheres, 2017). The corresponding helical_z_percentage 
parameter in RELION was set to 45%. The output volume was used as the reference model 
for 3D classification. 3D classification with different box sizes, from 192 to 400 pixels, resulted 
in 3D classes with the same range of twists, from 72˚ to 96˚ for the 1-mM AMPPNP dataset. 
The 224-pixel box produced the 2D class averages with the most clearly discernible secondary 
structure features and the 3D reconstruction of the highest resolution. A box size of 224 pixels 
were therefore selected for the full reconstruction. 
The segments were extracted from dose-weighted micrographs in 224-pixel boxes with a 44 
Å inter-box distance. For the 1 mM AMPPNP dataset, a total of 367,549 segments were 
extracted from the full dataset. Five rounds of reference-free 2D classification were performed 
to remove low-quality filaments, yielding 255,437 particles. 
The particles were subjected to 3D auto-refinement. Beam-induced motion of individual 
filament segments was corrected with movie refinement. B-factor weights were applied to each 
frame in particle polishing to compensate for radiation damage (Scheres, 2014). One round of 
2D classification was performed to discard low-quality classes, yielding 245,826 particles. The 
particles were divided into six classes in 3D classification with a local search of helical 
symmetry (twist 73°- 94° and rise 42.5 - 45.5 Å). A class with a 74.9° twist and 33,138 particles 
was selected and 3D auto-refined to 4.7 Å resolution. Further refinement with a soft mask 
around the filament produced a volume with 3.87 Å resolution and final twist 74.3˚. Helical 
symmetry was imposed on the unfiltered half-maps with relion_helix_toolbox (He and Scheres, 
2017), which improved the resolution to 3.68 Å after post-processing with a soft mask applied 
(Table 1). The 3D reconstruction was then sharpened with a B-factor of -175 Å-2. A second 
3D class with twist 90.8° and 39,987 particles processed following the same procedure, 
yielding a map with an overall resolution of 3.93 Å with a twist of 90.9˚. The overall map 
resolutions reported in Table 1 were derived from Fourier shell correlation (FSC) calculations 
between reconstructions from two independently refined half-maps (FSCmap2map), and 
reported resolutions are based on the gold-standard (FSC = 0.143 Å) criterion (Figure S2A-
C). Local resolution was estimated with RELION. 
In a parallel alternative processing workflow, all 255,437 particles from initial 2D classification 
were subjected to two more rounds of 2D classification, yielding 215,722 particles. The 
particles were divided into four classes in 3D classification, with local search of helical 
symmetry (twist 74° - 94° and rise 44 - 46 Å). A class with 66,565 particles (twist 86.5° and 
rise 44.4 Å) was selected and 3D auto-refined to 5.7 Å resolution. After particle polishing, 
additional 3D auto-refinement with a soft mask produced a density map at 4.13 Å resolution. 
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Further 3D classifications did not improve the density quality. Helical symmetry was imposed 
on the unfiltered half-maps, and a B-factor of -165 Å-2 was applied to the reconstruction, which 
had a resolution of 3.93 Å. We note that although the overall resolutions for the Twist87 and 
Twist91 structures were the same, the Twist87 density had a greater local resolution range 
than Twist91, with slightly higher resolution near the helical axis, and lower resolution away 
from the axis. 
The 2.5-mM AMPPNP, 10-mM ATP and 2-mM ADP-AlF4 datasets were processed using the 
same procedure as for the 1-mM AMPPNP dataset, except that the 2-mM ADP-AlF4 dataset 
was generated from merging data collected in separate sessions with different pixel sizes, of 
1.085 Å and 1.07 Å, respectively. The dataset with 1.085 Å pixel size was rescaled to 1.07 Å 
pixel size and then merged with the 1.07 Å-pixel-size dataset. 
Model building and refinement 
The crystal structure of human MDA5 bound to a 12-bp dsRNA oligonucleotide, PDB code 
4GL2 (Wu et al., 2013) was used as the starting atomic model for all three twist classes. The 
model was docked as a rigid body into the density for the central subunit in each reconstruction 
with UCSF Chimera (Pettersen et al., 2004). Initial docking was performed manually and was 
followed by real space fitting with the Fit in Map function. The positions of individual protein 
secondary structure elements and domain fragments were then sequentially refined using the 
Jiggle Fit script (Brown et al., 2015) in COOT (Emsley and Cowtan, 2004). Each model was 
then manually rebuilt in COOT to optimize the fit to the density, using the crystal structure of 
chicken MDA5 bound to a 10-bp dsRNA and ADP-Mg2+, PDB code 5JCF (Uchikawa et al., 
2016) as a guide for rebuilding in regions where the crystal structure of human MDA5 was 
disordered or had a more divergent conformation. The sequence of the dsRNA was randomly 
selected from the bacteriophage Φ6 genome and is purely representative since any RNA 
sequence-specific information was lost during helical symmetry averaging. The two adjacent 
subunits in the filament were then generated by applying the helical symmetry for each 
reconstruction from RELION to the respective rebuilt atomic model. The resulting models, 
containing three MDA5 subunits each, allowed the filament forming interfaces to be refined in 
subsequent real space refinement. The bases in the dsRNAs bound to each subunit were 
renumbered so they would be treated as a single 42/45-bp dsRNA in subsequent steps. Real 
space refinement was performed on the three-subunit models, in PHENIX 1.13 (Adams et al., 
2010), using the final helically averaged volumes from RELION as the maps for refinement. 
The global minimization and atomic displacement parameter (ADP) refinement options were 
selected in PHENIX. The following restraints were used in real space refinement: secondary 
structure restraints, non-crystallographic symmetry (NCS) restraints between the protein 
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subunits, side chain rotamer restraints, and Ramachandran restraints. Key refinement 
statistics are listed in Table 1. 
Model validation and analysis 
The FSC curve between the final model and full map after post-processing in RELION, 
FSC(model2map), is shown in Figures S2A-C. Cross-validation against overfitting was 
performed as described by Amunts et al. (Amunts et al., 2014). The atoms in each final atomic 
model were displaced by 0.25 Å in random directions. The shifted coordinates were then 
refined against one of the half-maps generated in RELION, the “work set”. This test refinement 
was performed with PHENIX using the same procedure as for the refinement of final models 
(see above). The other half-map, the “test set” was not used in refinement for cross-validation. 
FSC curves of the refined shifted model against the work set, FSCwork, and against the test 
set, FSCfree, are shown in Figures 2D-F. The FSCwork and FSCfree curves are not 
significantly different, consistent with the absence of overfitting in our final models. 
The quality of the atomic models, including basic protein and RNA geometry, Ramachandran 
plots, clash analysis, was assessed and validated with MolProbity (Chen et al., 2010) as 
implemented in PHENIX, and with the Worldwide PDB (wwPDB) OneDep System 
(https://deposit-pdbe.wwpdb.org/deposition). 
To determine which conformational state the helicase modules of the cryoEM structures were 
in, each model was superimposed onto the fully closed structure of LGP2 (PDB code 5JAJ 
(Uchikawa et al., 2016)) using conserved core secondary structure elements of Hel1 as the 
reference. The rotation angle relating the Hel2 domains of the aligned structures was found to 
be in 8.8˚- 9.5˚ for the filaments formed in the presence of ATP or AMPPNP and 3˚ for the 
ADP-AlF4-bound structure. The Hel1-Hel2 conformations are defined by (Uchikawa et al., 
2016) as follows: 0˚ - 3˚ for the closed state, 7˚ - 13˚ for the semi-closed state, ~40˚ for the 
semi-open state, and 50˚ - 60˚ for the open state. 
Luciferase reporter cell signalling assay 
HEK293T cells in 12-well plates were transfected with 400 ng ml-1 of firefly luciferase under 
control of the IFN-β promoter (pIFN-Luc, Promega), 40 ng ml-1 of Renilla luciferase under a 
constitutive promoter (pRL-TK, Promega), and 40 ng ml-1 of pLEXm vector (Aricescu et al., 
2006) containing either no insert, WT human MDA5∆L2 (pLEXm MDA5-∆644-663), or human 
MDA5-∆L2 with mutations generated by overlap PCR from WT MDA5-∆L2. All transfections 
were performed with polyethylenimine (Sigma-Aldrich). After expression for 6 h, cells were 
transfected with poly(I:C) (Tocris Bioscience). After 24 h, cell lysates were prepared, and 
luciferase activity was measured using Promega assay kits according to the manufacturer’s 
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instructions. Firefly luciferase activity was normalised against the co-transfected Renilla 
luciferase. 
ATPase assay 
Mouse MDA5 protein (WT or signaling-defective mutant) was diluted to a concentration of 75 
nM in a solution containing 2.25 nM 1-kb dsRNA, 1 mM ATP, 20mM HEPES pH 7.8, 0.15 M 
KCl, 1.5 mM MgCl2 and 1 mM DTT and incubated at 37˚C. Samples of the reaction were 
extracted and quenched with 20 mM EDTA at 20-s intervals. The concentration of inorganic 
phosphate released by hydrolysis of ATP was measured by tracking absorbance at 620 nm of 
malachite green binding to phosphate ions using the ATPase/GTPase activity colorimetric 
assay (Sigma-Aldrich). 
Fluorescence polarization AMPPNP binding assay 
The buffer used for this assay was 20 mM HEPES pH 7.8, 0.15 M KCl, 1.5 mM MgCl2 and 1 
mM DTT. Concentrations of 0.2 µM, 2 µM 10 µM and 20 µM Mant-AMPPNP (Jena Bioscience) 
were tested for fluorescent signal. 10 µM Mant-AMPPNP was selected for the assay as it was 
the minimum concentration required for detection of fluorescent signal relative to a blank 
containing 10 µM (1.14 g l-1) MDA5 and 0.303 g l-1 poly(I:C) RNA but no Mant-AMPPNP. 
Mouse MDA5 protein (WT or ATPase-defective mutant) was titrated from 0 to 40 µM into a 
solution containing 10 µM Mant-AMPPNP and poly(I:C) RNA at a 1:3 molar ratio of MDA5 to 
RNA binding sites, assuming 15 bp per binding site. The mixture was incubated for 1 h at room 
temperature in a black, flat-bottomed 384-well plate (Corning). Fluorescence polarization was 
measured with a Clariostar plate reader (BMG LABTECH) with an excitation wavelength of 
355 nm and an emission wavelength of 448 nm. 
 
QUANTIFICATION AND STATISTICAL ANALYSIS  
No statistical methods were used to predetermine sample size, experiments were not 
randomized, and the investigators were not blinded to experimental outcomes. Luciferase-
reporter cell signaling data are represented as the mean ± standard error of the mean of three 
replicates conducted in a single independent experiment. Data are representative of at least 
three independent experiments. 
 
DATA AVAILABILITY  
 33 
The atomic coordinates were deposited in the Protein Data Bank with codes 6G19, 6G1S, 
6G1X, 6GJZ, 6GKH, 6GKM, 6H61 and 6H66. The cryoEM densities were deposited in the EM 
Data Bank with codes 4338, 4340, 4341, 0012, 0023, 0024, 0143 and 0145. The raw electron 
micrographs were deposited in EMPIAR with codes 10208, 10209, 10210, 10211 and 10213. 
Full resolution original experimental images used in the figures and supplemental figures have 
been uploaded to Mendeley Data, doi:10.17632/djfd3yhtn5.1. Other data are available from 
the corresponding author upon reasonable request. 
 
Supplemental Movie Legends 
Movie S1. Atomic models of the MDA5-dsRNA filaments in four different states, Related to 
Figures 2, 4 and 7. 
Morphing between overviews of the refined atomic models of the MDA5-dsRNA filaments in 
the four states shown in Figure 7D: low-twist AMPNPN-bound (Twist74), intermediate-twist 
ADP-AlF4-bound, intermediate-twist low nucleotide-occupancy (Twist87) and high-twist low 
nucleotide-occupancy (Twist91). Three adjacent MDA5 protomers and bound dsRNA are 
shown. RNA is in magenta. The bound AMPPNP molecules are shown in ball-and-stick 
representation. The domains of the central MDA5 protomer are colored as in Figures 1, 2 and 
7: Hel1, light green; Hel2, cyan; Hel2i, yellow; pincer, red; C-terminal domain, orange. The two 
adjacent MDA5 protomers are shown in grey. 
 
Movie S2. Comparison of filament forming interface I in four different states, Related to 
Figures 2, 4 and 7. 
Zoom from overview to close-up of filament forming interface I, with morphing between the 
refined atomic models of the Twist74, ADP-AlF4-bound, Twist87 and Twist91 structures in the 
close-up view. Three adjacent MDA5 protomers and bound dsRNA are shown and colored as 
in Movie S1. 
 
Movie S3. Comparison of filament forming interface II in four different states, Related to 
Figures 2, 4 and 7. 
Zoom from overview to close-up of filament forming interface II, with morphing between the 
refined atomic models of the Twist74, ADP-AlF4-bound, Twist87 and Twist91 structures in the 
close-up view. Three adjacent MDA5 protomers and bound dsRNA are shown and colored as 
in Movies S1 and S2. 
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Movie S4. Comparison of filament forming interfaces in the different twist states of the 1-mM 
AMPPMP structures with side chain detail, Related to Figures 2, 4 and 7. 
Zoom from overview to close-up of the two filament forming interfaces, with morphing between 
the refined atomic models of the Twist74, Twist87 and Twist91 structures in close-up views 
showing the key filament forming side chains. Three adjacent MDA5 protomers and bound 
dsRNA are shown and colored as in the other movies. 
 
Movie S5. Movie highlighting the domain motions that accompany the transition from the ATP-
bound ground state to the nucleotide-free state via the ADP-AlF4-bound transition state 
intermediate, Related to Figures 2, 4 and 7.   
Close-ups of the Hel1 and Hel2 domains (green and cyan, respectively), with morphing 
between the refined atomic models of the Twist74 (ATP-bound), ADP-AlF4-bound, and 
Twist87 (nucleotide-free) structures. Two orthogonal views are shown. The first view highlights 
the transition to and from the closed Hel1-Hel2 conformation, in the ADP-AlF4-bound structure. 
The second view highlights the motion of the Hel2-loop, and the distortions of the dsRNA 
duplex that accompany the transition to and from the closed Hel1-Hel2 conformation, in the 
ADP-AlF4-bound structure. MDA5 protomers and bound dsRNA are colored as in the other 
movies. 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Anti-FLAG primary antibody Sigma-Aldrich F1804 
Anti-actin primary antibody Abcam AC-40 (ab11003) 
Anti-mouse IgG (H+L) DyLight™ 800 4X PEG Conjugate Cell Signaling 5257 
Bacterial and Virus Strains  
Escherichia coli BL21(DE3) cells Merck 69450 
Biological Samples   
Bacteriophage Φ6 genomic dsRNA  ThermoFisher F630 (Discontinued) 
Chemicals, Peptides, and Recombinant Proteins 
384-well plate, black, clear flat bottom Corning 3540 
AlCl3  Alfa Aesar 14552.14 
ADP Sigma-Aldrich A2754 
AMPPNP Sigma-Aldrich 10102547001 
ATP Sigma-Aldrich A6419-1G 
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Ribonucleotide Solution Mix New England Biolabs N0466 
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T7 RNA Polymerase New England Biolabs M0251L 
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PureLink RNA Mini Kit ThermoFisher 12183018A 
Deposited Data 
Full resolution original images used in figures and 
supplemental figures 
Mendeley Data doi:10.17632/djfd3yh
tn5.1 
MDA5-dsRNA 1-mM AMPPNP low-twist atomic 
coordinates 
Protein Data Bank 6G19 
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coordinates 
Protein Data Bank 6G1S 
MDA5-dsRNA 1-mM AMPPNP high-twist atomic 
coordinates 
Protein Data Bank 6G1X 
MDA5-dsRNA 2.5-mM AMPPNP low-twist atomic 
coordinates 
Protein Data Bank 6GJZ 
MDA5-dsRNA 2-mM ADP-AlF4 low-twist atomic 
coordinates 
Protein Data Bank 6GKH 
MDA5-dsRNA 10-mM ATP low-twist atomic coordinates Protein Data Bank 6GKM 
Key Resource Table
MDA5-dsRNA no nucleotide intermediate-twist atomic 
coordinates 
Protein Data Bank 6H61 
MDA5-dsRNA no nucleotide high-twist atomic 
coordinates 
Protein Data Bank 6H66 
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MDA5-dsRNA intermediate-twist EM map EM Data bank 4340 
MDA5-dsRNA high-twist EM map EM Data bank 4341 
MDA5-dsRNA 2.5-mM AMPPNP low-twist EM map EM Data bank 0012 
MDA5-dsRNA 2-mM ADP-AlF4 low-twist EM map EM Data bank 0023 
MDA5-dsRNA 10-mM ATP low-twist EM map EM Data bank 0024 
MDA5-dsRNA no nucleotide intermediate-twist EM map EM Data bank 0143 
MDA5-dsRNA no nucleotide high-twist EM map EM Data bank 0145 
MDA5-dsRNA 1-mM AMPPNP cryoEM dataset EMPIAR 10213 
MDA5-dsRNA 2.5-mM AMPPNP cryoEM dataset EMPIAR 10209 
MDA5-dsRNA 2-mM ADP-AlF4 cryoEM dataset EMPIAR 10211 
MDA5-dsRNA 10-mM ATP cryoEM dataset EMPIAR 10208 
MDA5-dsRNA no nucleotide cryoEM dataset EMPIAR 10210 
Experimental Models: Cell Lines 
Human embryonic kidney (HEK) 293T cells   
Recombinant DNA 
pET28a Merck 69864 
pCold-TF TAKARA  
pIFN-Luc Promega  
pRL-TK Promega  
pLEXm (Aricescu et al., 2006) N/A 
Software and Algorithms 
ImageJ NIH https://imagej/nih/go
v/ij 
EPU Automated Data Acquisition Software for Single 
Particle Analysis v1.9.1 
ThermoFisher https://www.fei.com/
software/epu/ 
RELION v2.1.0 (Scheres, 2012) https://www2.mrc-
lmb.cam.ac.uk/relion
/index.php?title=Mai
n_Page 
MOTIONCOR2 (Zheng et al., 2017) http://msg.ucsf.edu/e
m/software/motionco
r2.html 
Gctf v1.06 (Zhang, 2016) N/A 
Coot v0.8.9  (Emsley and Cowtan, 
2004) 
https://www2.mrc-
lmb.cam.ac.uk/perso
nal/pemsley/coot/ 
PHENIX v1.13 (Adams et al., 2010) http://www.phenix-
online.org 
UCSF Chimera UCSF Resource for 
Biocomputing, 
Visualization and 
Informatics 
https://www.cgl.ucsf.
edu/chimera/ 
Other 
In vitro-transcribed 1-kb dsRNA  This paper N/A 
QUANTIFOIL R1.2/1.3 grids  Quantifoil Micro Tools R1.2/1.3 
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Supplemental Figure Legends 
Figure S1. CryoEM image processing of mouse MDA5-dsRNA helical filaments, Related to 
Figure 1. 
(A) Raw cryo-electron micrograph of MDA5-dsRNA filaments imaged in the presence of 1 mM 
AMPPNP. Genomic bacteriophage Φ6 genomic RNA was used as the dsRNA. The scale bar 
is 100 nm. The filament segment used for the Fourier transform in (B) is marked with a black 
rectangle. 
(B) Fast Fourier transform (power spectrum) of the boxed region in (A) showing the helical 
layer lines. Red lines mark the meridian (n = 0) and first meridional reflection (n = 1). This 
distance between the meridian and the n = 1 layer line corresponds to the helical rise of the 
one-start helix. 
(C) A selected 2D class average of MDA5-dsRNA filaments. The box size is 719 Å. 
(D) Fast Fourier transform (power spectrum) of the 2D class average in (C). Red lines mark 
the meridian (n = 0) and the n = 1 layer line to indicate the helical rise. 
(E) 2D class averages of MDA5-dsRNA filaments used for cryoEM reconstruction. The box 
size is 240 Å. This was the box size that was used in image reconstruction. 
 
Figure S2. Data and model quality assessment by Fourier shell correlation analysis, Related 
to Figures 1 and S3 and the STAR Methods. 
(A-C) Fourier Shell Correlations (FSC) of reconstructions of filaments with 1 mM AMPPNP 
from two independently refined half-maps (map2map, in blue); and of the reconstruction from 
the whole dataset versus a map calculated from the refined atomic model (model2map, in 
red). The gold-standard cutoff (FSC = 0.143) and the FSC = 0.5 level are marked with dashed 
lines. The resolution values of each curve at these levels are indicated. (A), FSC plots for the 
Twist74 structure; (B), Twist87; (C), Twist91. 
(D-F) FSC plots for cross-validation as described by Amunts et al. (Amunts et al., 2014). 
FSCwork (red), FSC of refined test model versus work set (half-map used in test refinement). 
FSCfree (blue), FSC of refined test model versus test set (half-map not used in test 
refinement). The FSC = 0.5 level is indicated by a dashed line. (D), FSCwork and FSCfree 
plots for the Twist74 structure; (E), Twist87; (F), Twist91. 
(G-J) Map2map and model2map FSC plots of reconstructions from filaments in the presence 
of 2.5 mM AMPPNP (77˚ twist) (G), 10 mM ATP (73˚ twist) (H),  2 mM ADP-AlF4 (88˚ twist) (I), 
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or without any added nucleotide (J). The gold-standard cutoff (FSC = 0.143) and the FSC = 
0.5 level are marked with dashed lines. The resolution values of each curve at these levels 
are indicated. (K) Flow chart showing the workflow pipeline for cryoEM image processing, 
classification and model refinement, as described in the Methods. 
 
Figure S3. Local resolution estimation for the three cryoEM reconstructions and samples of 
local cryoEM density, Related to Figures 1-3 and S2. 
(A) Local resolution estimation for the cryoEM volumes obtained from samples in the presence 
of 1 mM AMPPNP, 2.5 mM AMPPNP, 10 mM ATP, 2 mM ADP-AlF4, or without added 
nucleotide. The maps and resolution values were calculated in RELION 2.1 (Scheres, 2012). 
(B) Representative samples of local cryoEM density from the Twist74 structure (1 mM 
AMPPNP) with fitted and refined atomic models. A contour level (sdLevel) of 1.0 in USCF 
Chimera (Pettersen et al., 2004) was used for all panels. 
 
Figure S4. Structural alignment of the cryoEM and crystal structures of MDA5 bound to 
dsRNA, Related to Figures 4 and S5. 
The Twist74 cryoEM structure (blue) was used as the alignment reference. Twist87 is in pink, 
Twist91 in brown, chicken MDA5 (PDB code 5JCF) in grey and human MDA5 (PDB code 
4GL2) in white. The root mean square deviations between the three cryoEM structures and 
the crystal structures of hMDA5 and chMDA5 range from 1.09 Å to 1.63 Å (main chain atoms), 
with Twist74 and chicken MDA5 bound to a 10-bp dsRNA and ADP-Mg2+ being the most 
similar. 
(A) Side view, with the helical axis of dsRNA vertical. The regions that would form filament 
contacts with the pincer domain of an adjacent filament protomer are boxed. Close-ups of the 
boxed regions are shown in (C) and (D) as labeled in the panel. 
(B) Top view, with the helical axis perpendicular to the image plane.  
(C) Close-up view of the C-terminal tail, which forms most of the contacts with the second 
pincer helix in filament-forming Interface II in the cryoEM structures. The C-terminus of each 
atomic model is labeled with “C”. 
(D) Close-up view of Hel1 interface loop, which forms most of the contact with the first pincer 
helix in filament-forming Interface I in the cryoEM structures. 
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Figure S5. Amino acid sequence alignment of MDA5 from mouse, human and chicken, 
Related to Figures 4 and S4. 
The CARDs and linker between the CARDs and Hel1 are missing from all dsRNA-bound 
structures and are not shown in the alignment for clarity. Amino acids that were present in the 
experimental sample but unstructured in the crystal structures (PDB codes 4GL2 and 5JCF) 
or cryoEM structures of MDA5 bound to dsRNA are shown in grey typeface. Amino acids that 
were not present in the crystallized or imaged proteins are shown in outline font. The residues 
in a surface loop in Hel2i that were deleted to improve solubility (646–663 in mouse MDA5 
and 644-663 in human MDA5) are highlighted in yellow. These sequences are not conserved 
in vertebrate MDA5 genes and their deletion does not affect the dsRNA binding, ATPase or 
interferon signaling activities of MDA5 (see (Berke et al., 2012; Wu et al., 2013), in 
supplementary information). The secondary structure of mouse MDA5 is shown above the 
sequences. This figure was generated in part with ESPript (Robert and Gouet, 2014). 
 
Figure S6. Differences in the relative domain positions and filament contacts in the cryoEM 
structures with different helical twists, Related to Figure 4. 
(A) Overview of the Twist74 structure for reference, viewed along the helical axis with the 
pincer domain in the foreground (long helices on the left).  
(B-F) Protomers from the Twist74, Twist87 and Twist91 structures (not shown) were 
superimposed on each other using the pincer domain the reference. The adjacent protomers 
from each twist class are shown to highlight the differences in relative domain orientations. 
(B), Hel1 domains; (C), Hel2 domains; (D), Hel2i domains; (E), pincer domains; (F) CTDs. The 
highlighted domains are colored as follows: Twist74, blue; Twist87, pink; Twist91, brown.  The 
remaining domains are shown in transparent grey representation for clarity. The outer contour 
of the superimposed structures is shown for reference as a black outline. 
 
Figure S7. Filament formation and cell signaling activities of additional MDA5 filament 
formation interface mutants, Related to Figures 5 and 6. 
(A) Representative electron micrographs of WT MDA5 and filament interface mutants not 
shown in Figure 6 in the presence of 1 kb dsRNA, 1 mM AMPPNP and 5 mM MgCl2. Scale 
bars are 100 nm. Residue numbers refer to the mouse MDA5 sequence. 
(B) IFN-β reporter cell signaling assays of WT MDA5 and mutants not shown in Figure 6. The 
relative luciferase activity for each variant was measured as in Figure 6. Residue numbers 
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refer to the human MDA5 sequence. Error bars represent standard error of the mean between 
measurements; n = 3. *P < 0.05; **P < 0.01; one tailed and unpaired t-test compared to wild-
type data, n = 3. 
(C-D) MDA5 filament forming interface mutants are purified as monomers and do not form 
filaments or oligomers in the absence of dsRNA. (C) Representative electron micrographs of 
selected WT MDA5 and filament interface mutants in the absence of dsRNA and in the 
presence of 1 mM AMPPNP and 5 mM MgCl2. Scale bars are 100 nm. Residue numbers refer 
to the mouse MDA5 sequence. The insets show a 4x magnification of an area within each 
respective micrograph. (D) Size-exclusion chromatograms for WT, D848K/F849A, E875A, 
E883R/K884A and D1014A/Y1015A/E1017K. Elution volumes are consistent with monomeric 
protein. Chromatography was performed with a Superdex 200 Increase (10/300) column (GE 
Healthcare). 
(E) Fluorescence polarization assay of MDA5 binding to Mant-AMPPNP. WT MDA5 and the 
two mutants defective in ATPase activity (see Figure 5) were titrated into a solution containing 
poly(I:C) RNA and 10 µM Mant-AMPPNP. Binding of Mant-AMPPNP to MDA5 was measured 
as fluorescence polarization (lex = 355 nm, lem = 448 nm). Error bars represent standard error 
of the mean between measurements in different wells; n = 3. 
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          Mouse    IAD  R  PF E   EIM  IQ YCQ  P S FG Q YEQW I  E  AAK   RK RVV      K KLL          D  T     A  KK   D   D  DT EN AS T KS M H QM GN  600
          Human  IAD R PF E EIM IQ YCQ P S FG Q YEQW I E AAK RK RV
        Chicken  IAD  R  PF E   EIM  IQ YCQ  P S FG Q YEQW I  E  AAK   RK RVV      R RII          E  S     V  RR   E   E  DK RD QD K LY K P RE EK  591
α10 α11 
     R   E          I   T   T   E   K                           E N E D F VIE  659
     R   E          I   S   T   D   K                       
                                                            
       610       620       630       640       650       659
          Mouse  CAEHL KYN ALQINDTIRM DAY HL  FY  K  K A D
          Human  CAEHL KYN ALQINDTIRM DAY HL FY K K A D
        Chicken CAEHL KYN ALQINDTIRM DAY HL  FY   K  K A   D                     K   D          V   N  N  E  R   N K L R T ESD D............... 636
α12 α13 
E T E E F VLN S .  659
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